TherapeuticsMD (TXMD) Return on Capital Employed Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562.00 |
| Dec 31, 2025 | 365.00 |
| Sep 30, 2025 | 934.00 |
| Jun 30, 2025 | 957.00 |
| Mar 31, 2025 | 198.00 |
| Dec 31, 2024 | 448.00 |
| Sep 30, 2024 | -13,023.00 |
| Jun 30, 2024 | -8,880.00 |
| Mar 31, 2024 | -4,876.00 |
| Dec 31, 2023 | -2,311.00 |
| Sep 30, 2023 | -13,244.00 |
| Jun 30, 2023 | -37,849.00 |
| Mar 31, 2023 | -8,374.00 |
| Dec 31, 2022 | -21,884.00 |
| Sep 30, 2022 | 35,517.00 |
| Jun 30, 2022 | 52,966.00 |
| Mar 31, 2022 | 20,295.00 |
| Dec 31, 2021 | 35,005.00 |
| Sep 30, 2021 | 252.00 |
| Jun 30, 2021 | 475.00 |